Lung Cancer
Volume 69, Issue 1 , Pages 66-70, July 2010

Limited contamination in the Dutch–Belgian randomized lung cancer screening trial (NELSON)

  • Eleonora Baecke

      Affiliations

    • Department of Public Health, Erasmus MC – University Medical Center Rotterdam, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands
    • Department of Pulmonology, Erasmus MC – University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author at: Department of Public Health, Room Ae-134, Erasmus MC, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands. Tel.: +31 10 7044634.
  • ,
  • Harry J. de Koning

      Affiliations

    • Department of Public Health, Erasmus MC – University Medical Center Rotterdam, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands
  • ,
  • Suzie J. Otto

      Affiliations

    • Department of Public Health, Erasmus MC – University Medical Center Rotterdam, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands
  • ,
  • Carola A. van Iersel

      Affiliations

    • Department of Public Health, Erasmus MC – University Medical Center Rotterdam, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands
    • Department of Pulmonology, Erasmus MC – University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands
    • Albert Schweitzer Hospital, P.O. Box 444, 3300 AK Dordrecht, The Netherlands
  • ,
  • Rob J. van Klaveren

      Affiliations

    • Department of Pulmonology, Erasmus MC – University Medical Center Rotterdam, 3000 CA Rotterdam, The Netherlands

Received 24 June 2009; received in revised form 17 August 2009; accepted 19 August 2009. published online 05 October 2009.

Abstract 

Purpose of this study was to determine the rate of contamination, defined as lung cancer screening in the control arm, of the Dutch–Belgian randomized lung cancer screening trial (NELSON) as contamination adversely affects the power of a trial. The NELSON cohort includes 15,822 high-risk current and former smokers, aged 50–75 years, equally randomized to the screen and control arm. Questionnaires were sent to a sample of 1460 male subjects of the control arm, stratified on smoking determinants. The response rate was 73.0%. The participants were asked whether they received a chest X-ray or CT scan in the last 4 years and, if so, when and for what reason it had been performed. Examinations performed after randomization because of “Precaution” or “No examination was offered by NELSON” were regarded as contamination. In the first 24 months after randomization 3.1% (2.3–3.8%) of the respondents received a lung cancer screening examination. Contamination reached a non-significant peak within the first 3 months after randomization, with a lower limit of 2.5 and an upper limit of 3.1 per 1000 person-months. This screening rate did not differ from the background rates in the last 18 months before randomization. No significant differences were observed between current and former smokers. In conclusion, the rate of contamination among male subjects of the control arm of the NELSON trial is low and is not likely to jeopardize the power of the trial.

Keywords: Contamination, Lung cancer, Lung neoplasms, Screening, Mass screening, Early detection of cancer, Tomography spiral computed, Randomized controlled trial, NELSON trial, Power

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0169-5002(09)00476-0

doi:10.1016/j.lungcan.2009.08.015

Lung Cancer
Volume 69, Issue 1 , Pages 66-70, July 2010